266 related articles for article (PubMed ID: 29224677)
21. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
22. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
[TBL] [Abstract][Full Text] [Related]
23. From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers.
Lambers WM; Westra J; Bootsma H; de Leeuw K
Semin Arthritis Rheum; 2021 Feb; 51(1):43-48. PubMed ID: 33360229
[TBL] [Abstract][Full Text] [Related]
24. Detection of epitopes in systemic lupus erythematosus using peptide microarray.
Li X; Li H; Hu Q; Lin J; Zhang Q; Li Y; Li J; Chen T; Zhang Q; Qiu Y
Mol Med Rep; 2018 May; 17(5):6533-6541. PubMed ID: 29532871
[TBL] [Abstract][Full Text] [Related]
25. Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.
Nozawa K; Doe K; Uomori K; Sekigawa I; Takasaki Y; Yamaji K; Tamura N
Autoimmunity; 2017 Jun; 50(4):241-246. PubMed ID: 28553742
[TBL] [Abstract][Full Text] [Related]
26. Combined Assay for Detecting Autoantibodies to Nucleic Acids and Apolipoprotein H in Patients with Systemic Lupus Erythematosus.
Khatri S; Mellins ED; Torok KS; Bukhari SA; Astakhova K
Methods Mol Biol; 2020; 2063():57-71. PubMed ID: 31667763
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
[TBL] [Abstract][Full Text] [Related]
28. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W; Wu H; Zhao M; Lu Q
Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
[TBL] [Abstract][Full Text] [Related]
30. Contemporary concepts for the clinical and laboratory evaluation of systemic lupus erythematosus and "lupus-like" syndromes.
Nakamura RM; Bylund DJ
J Clin Lab Anal; 1994; 8(6):347-59. PubMed ID: 7869173
[TBL] [Abstract][Full Text] [Related]
31. Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
Harden OC; Hammad SM
Front Immunol; 2020; 11():586737. PubMed ID: 33101319
[TBL] [Abstract][Full Text] [Related]
32. [Unmet needs in systemic lupus erythematosus].
Ichinose K
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):396-407. PubMed ID: 29367524
[TBL] [Abstract][Full Text] [Related]
33. Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus.
Kwon OC; Lee JS; Ghang B; Kim YG; Lee CK; Yoo B; Hong S
Semin Arthritis Rheum; 2018 Dec; 48(3):462-466. PubMed ID: 29566965
[TBL] [Abstract][Full Text] [Related]
34. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.
Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H
J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies in SLE: prediction and the
Choi MY; Fritzler MJ
Lupus; 2019 Oct; 28(11):1285-1293. PubMed ID: 31399014
[TBL] [Abstract][Full Text] [Related]
36. Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges.
Chen J; Liao S; Zhou H; Yang L; Guo F; Chen S; Li A; Pan Q; Yang C; Liu HF; Pan Q
Front Immunol; 2021; 12():816956. PubMed ID: 35116040
[TBL] [Abstract][Full Text] [Related]
37. Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.
Korte EA; Gaffney PM; Powell DW
Arthritis Res Ther; 2012 Feb; 14(1):204. PubMed ID: 22364570
[TBL] [Abstract][Full Text] [Related]
38. Autoantibody profiling reveals four protein candidate autoantigens associated with systemic lupus erythematosus.
Frostegård J; Hellström C; Nilsson P; Frostegård AG; Ajeganova S
Lupus; 2018 Sep; 27(10):1670-1678. PubMed ID: 30041579
[TBL] [Abstract][Full Text] [Related]
39. Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry.
Ferreira TAR; de Andrade HM; de Pádua PM; Carvalho MDG; Pires SDF; Oliveira IHR; Lima BSS; Fialho Júnior LC; Cicarini WB; Chapeourouge DA; Perales JH; Guimarães TMPD; Toledo VPCP
Autoimmunity; 2017 Jun; 50(4):247-256. PubMed ID: 28675715
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
